Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

COVID-19 Update

19 Mar 2020 07:00

RNS Number : 7187G
Crest Nicholson Holdings PLC
19 March 2020
 

The information contained in this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

 

Crest Nicholson Holdings plc

(the "Company" or "Crest Nicholson")

 

COVID-19 Update

 

Crest Nicholson today issues an update on the impact of COVID-19 on the business and in advance of its Annual General Meeting ("AGM") which will be held at 10.30 a.m. on Tuesday 24 March 2020 at Brooklands Hotel, Brooklands Drive, Weybridge, Surrey KT13 0SL.

Since the start of the calendar year, up to and including 16 March 2020, we have traded in-line with our expectations and have seen continued improvements in website traffic, footfall and reservations. We have also made strong progress in implementing the changes to our business model and operations that we outlined in our updated strategy at the end of January 2020.

However, the Board has carefully considered this week's rapidly evolving Government guidance in respect of COVID-19 and expects this to have a significant impact on visitor levels, production capability and trading performance over an unclear timeline. Accordingly, the Company has taken the difficult decision to cancel its final dividend of 21.8 pence per share, otherwise payable on 9 April 2020. Resolution 2 will therefore be withdrawn from next week's AGM.

In addition, the Company also announces that it is suspending all existing financial guidance until both the severity and duration of the COVID-19 impact becomes clearer.

The Board recognises that these are significant steps to take, but when faced with this unprecedented and unpredictable situation, considers it to be prudent to protect the Company's cash position and maintain a robust balance sheet. The Executive Leadership Team has also moved quickly in identifying further measures that will increase cash generation, and reduce cash outflow, enabling the business to trade through this period of prolonged uncertainty.

The Company has made arrangements to fully draw its £250m revolving credit facility, resulting in available cash of £185m. In the ordinary course of business, the Company has a strong balance sheet and has made good progress in reducing levels of capital employed in the current financial year. The Board has only considered it necessary to take such decisive action because of the anticipated impact from COVID-19.

We consider these measures to be in the best interests of all our stakeholders and will best ensure the long-term viability of the business at this time. Our number one priority will always be the health and welfare of our employees and sub-contractors and we are also taking the necessary steps to maintain that commitment.

 

For further information, please contact:

 

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

 

Finsbury +44 (0) 20 7251 3801

Faeth Birch

Philip Walters

 

The person responsible for arranging the release of this announcement on behalf of the Company is Kevin Maguire, General Counsel & Company Secretary.

 

19 March 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRXVLLFBXLFBBE
Date   Source Headline
29th May 202610:34 amRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
21st May 20269:52 amRNSHolding(s) in Company
20th May 20262:28 pmRNSHolding(s) in Company
19th May 20267:00 amRNSRevised date for the half year results
12th May 20262:09 pmRNSDirector/PDMR Shareholding
1st May 20264:26 pmRNSHolding(s) in Company
30th Apr 20264:04 pmRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
28th Apr 20262:56 pmRNSDirector/PDMR Shareholding
24th Apr 20264:47 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTrading Update
20th Apr 20265:21 pmRNSHolding(s) in Company
10th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20269:57 amRNSAdmission to Trading
31st Mar 20263:23 pmRNSTotal Voting Rights
26th Mar 20263:24 pmRNSDirector/PDMR Shareholding
25th Mar 202611:59 amRNSResult of AGM
25th Mar 20267:00 amRNSTrading Statement
24th Mar 20268:45 amRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:22 pmRNSDirector/PDMR Shareholding
27th Feb 20262:37 pmRNSTotal Voting Rights
17th Feb 202610:38 amRNSAnnual Report & Notice of AGM
10th Feb 20265:04 pmRNSDirector/PDMR Shareholding
30th Jan 20262:11 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSFinal Results
12th Jan 20265:02 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSTotal Voting Rights
23rd Dec 20253:46 pmRNSTotal Voting Rights
10th Dec 20254:07 pmRNSDirector/PDMR Shareholding
5th Dec 202510:22 amRNSDirector Declaration
28th Nov 20252:55 pmRNSTotal Voting Rights
19th Nov 202512:59 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:32 pmRNSDirector/PDMR Shareholding
5th Nov 202510:40 amRNSHolding(s) in Company
31st Oct 20255:07 pmRNSTotal Voting Rights
28th Oct 202511:06 amRNSHolding(s) in Company
28th Oct 202510:02 amRNSDirectorate Change
24th Oct 20253:05 pmRNSHolding(s) in Company
17th Oct 202510:08 amRNSBlock listing Interim Review
10th Oct 20254:21 pmRNSDirector/PDMR Shareholding
30th Sep 202512:07 pmRNSTotal Voting Rights
22nd Sep 20252:48 pmRNSHolding(s) in Company
11th Sep 20254:07 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:48 pmRNSHolding(s) in Company
29th Aug 20251:28 pmRNSTotal Voting Rights
13th Aug 20259:58 amRNSDirector/PDMR Shareholding
1st Aug 20254:46 pmRNSHolding(s) in Company
31st Jul 20252:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.